Benjamin Hohl

Companies

• Enliven Therapeutics, Inc.Chief financial officer Feb 27, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN38,000 shares²$1.4M at $37.32Sep 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 17, 2026Sold 289 shares at $51.49 of Enliven Therapeutics, Inc.²
• Sep 17, 2026Sold 2,194 shares at $50.72 of Enliven Therapeutics, Inc.²
• Sep 17, 2026Sold 3,535 shares at $50.03 of Enliven Therapeutics, Inc.²
• Sep 17, 2026Exercised options 3,982 shares at $14.85 of Enliven Therapeutics, Inc.²
• Aug 17, 2026Sold 1,388 shares at $59.35 of Enliven Therapeutics, Inc.³
• Aug 17, 2026Sold 4,630 shares at $58.35 of Enliven Therapeutics, Inc.³
• Jul 17, 2026Sold 123 shares at $53.87 of Enliven Therapeutics, Inc.⁴
• Jul 17, 2026Sold 2,638 shares at $53.38 of Enliven Therapeutics, Inc.⁴
• Jul 17, 2026Sold 2,564 shares at $52.32 of Enliven Therapeutics, Inc.⁴
• Jul 17, 2026Sold 369 shares at $51.48 of Enliven Therapeutics, Inc.⁴
• Jul 17, 2026Sold 324 shares at $49.97 of Enliven Therapeutics, Inc.⁴
• Jul 17, 2026Exercised options 1,072 shares at $2.48 of Enliven Therapeutics, Inc.⁴
• Jun 17, 2026Sold 1,238 shares at $44.75 of Enliven Therapeutics, Inc.⁵
• Jun 17, 2026Sold 3,401 shares at $43.86 of Enliven Therapeutics, Inc.⁵
• Jun 17, 2026Sold 1,379 shares at $42.79 of Enliven Therapeutics, Inc.⁵
• Jun 17, 2026Exercised options 6,018 shares at $2.48 of Enliven Therapeutics, Inc.⁵
• Mar 6, 2026Sold 10,000 shares at $29.58 of Enliven Therapeutics, Inc.⁶
• Feb 12, 2026Granted 25,000 shares of Enliven Therapeutics, Inc.⁷
• Dec 22, 2025Exercised options 13,000 shares at $2.48 of Enliven Therapeutics, Inc.⁸
• Sep 29, 2025Sold 3,250 shares at $20.40 of Enliven Therapeutics, Inc.⁹
• Sep 29, 2025Exercised options 3,250 shares at $2.48 of Enliven Therapeutics, Inc.⁹
• Aug 27, 2025Sold 3,250 shares at $20.63 of Enliven Therapeutics, Inc.¹⁰
• Aug 27, 2025Exercised options 3,250 shares at $2.48 of Enliven Therapeutics, Inc.¹⁰
• Jul 28, 2025Sold 65 shares at $21.30 of Enliven Therapeutics, Inc.¹¹
• Jul 28, 2025Sold 3,185 shares at $20.45 of Enliven Therapeutics, Inc.¹¹